Flag of the European Union EU Clinical Trials Register Help

Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:
  • interventional clinical trials that are conducted in the European Union (EU) and the European Economic Area (EEA);
  • clinical trials conducted outside the EU / EEA that are linked to European paediatric-medicine development.
  • Learn   more about the EU Clinical Trials Register   including the source of the information and the legal basis.


    The EU Clinical Trials Register currently displays   33728   clinical trials with a EudraCT protocol, of which   5463   are clinical trials conducted with subjects less than 18 years old.
    The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    33,729 result(s) found. Displaying page 1 of 1,687.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2004-001823-39 Sponsor Protocol Number: 103502 Start Date*: 2004-11-15
    Sponsor Name:GlaxoSmithKline Biologicals
    Full Title: An open, randomized, controlled, phase II study to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals’ 11-valent pneumococcal conjugate vaccine, when administered intramuscularly...
    Medical condition: Prophylactic vaccination against pneumococcal diseases in infants and diseases caused by Neisseria meningitidis C.
    Disease:
    Population Age: Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-000773-60 Sponsor Protocol Number: SNMC 301 Start Date*: 2004-10-22
    Sponsor Name:Healthcare & Pharma Consulting AG (Europe)
    Full Title: 52 week multicenter, randomized, double-blind placebo-controlled trial evaluating the efficacy and safety of SNMC in patients with chronic hepatitis C
    Medical condition: Chronic hepatitis C
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-002803-34 Sponsor Protocol Number: Cetcapox-RT_31.08.2004 Start Date*: 2004-12-23
    Sponsor Name:Klinik und Poliklinik fuer Strahlentherapie, Universität Erlangen-Nürnberg
    Full Title: Phase I/II-Studie Praeoperative Radiochemotherapie mit Capecitabin plus Oxaliplatin und Cetuximab beim lokal fortgeschrittenen Rektumkarzinom im UICC-Stadium II und III
    Medical condition: Rektumkarzinom
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-002102-30 Sponsor Protocol Number: CC-5013-MM-012 Start Date*: 2005-02-17
    Sponsor Name:CELGENE EUROPE LIMITED
    Full Title: OPEN-LABEL, SINGLE-ARM STUDY OF THE SAFETY AND EFFICACY OF CC-5013 MONOTHERAPY FOR SUBJECTS WITH MULTIPLE MYELOMA A COMPANION STUDY FOR STUDIES THAL-MM-003, CC-5013-MM-009, AND CC-5013-MM-010
    Medical condition: Multiple Myeloma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10028228 Multiple myeloma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-001633-42 Sponsor Protocol Number: hp001 Start Date*: 2005-01-06
    Sponsor Name:NHS GRAMPIAN
    Full Title: Is there a role for Helicobacter pylori eradication in the treatment of laryngopharyngeal reflux? : A double blinded randomised case controlled clinical trial
    Medical condition: LARYNGOPHARYNGEAL ACID REFLUX
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2004-005012-80 Sponsor Protocol Number: S245.4007 Start Date*: 2005-03-03
    Sponsor Name:Solvay Pharmaceuticals GmbH
    Full Title: Double-blind, multicenter, randomized, placebo-controlled, parallel-group study to investigate the effect of Creon 25 000 Minimicrospheres on body mass index (BMI) in patients after gastrectomy.
    Medical condition: Patients atleast 18 years old with total or subtotal gastrektomy.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-005019-28 Sponsor Protocol Number: P00996 Start Date*: 2005-05-09
    Sponsor Name:Papworth Hospital NHS Foundation Trust
    Full Title: Diabetes therapy to improve body mass index pulmoanry function in cystic fibrosis subjects with abnormal blood glucose
    Medical condition: Cystic fibrosis related diabetes mellitus
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-001010-13 Sponsor Protocol Number: escit01 Start Date*: 2004-10-25
    Sponsor Name:Dept. of Neurology, Odense University Hospital
    Full Title: Escitalopram til behandling af smerter ved polyneuropati En dobbeltblind, randomiseret, placebokontrolleret undersøgelse (Escitalopram as a treatment for painful polyneuropathy: A double-blind, r...
    Medical condition: painful polyneuropathy of different origin
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-004633-33 Sponsor Protocol Number: bosex Start Date*: 2005-02-15
    Sponsor Name:Sexological Clinic, Rigshospitalet
    Full Title: local botox administration on patients with vulvar vestbulitis
    Medical condition: Vulvar vestibulits
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-004670-88 Sponsor Protocol Number: 4975-2-007-2 Start Date*: 2005-05-23
    Sponsor Name:AlgoRx Pharmaceuticals, Inc.
    Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects after Inguinal Hernia Repair
    Medical condition: Inguinal Hernia
    Disease: Version SOC Term Classification Code Term Level
    7.1 10022020 LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DK (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-004675-11 Sponsor Protocol Number: 133/2004/U Start Date*: 2004-09-14
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: Clinical trial of phase II for the a front line treatment of the non-Hodgkin lymphomas of derivation lymphocyte T Gemcitabine and Oxaliplatin GEMOX
    Medical condition: Non Hodgkin s disease of lymphocyte T derivation
    Disease: Version SOC Term Classification Code Term Level
    6.1 10025321 HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2004-002643-27 Sponsor Protocol Number: 2939089 Start Date*: 2004-10-14
    Sponsor Name:Orion Pharma GmbH
    Full Title: Efficacy and tolerability of Comtess® versus Cabaseril® as add-on to levodopa in the treatment of Parkinsonian patients suffering from wearing- off phenomenon
    Medical condition: Parkinson´s disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-000835-27 Sponsor Protocol Number: NW-1015/017/III/2003 Start Date*: 2004-12-03
    Sponsor Name:NEWRON PHARMACEUTICALS
    Full Title: A phase III, double-blind, placebo-controlled, 12-month extension study to investigate the efficacy and safety of a dose range of safinamide of 50-200 mg/day, as add-on therapy in patients with ear...
    Medical condition: Parkinson's Disease
    Disease: Version SOC Term Classification Code Term Level
    6.1 10061536 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed) ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-000049-12 Sponsor Protocol Number: STH13889 Start Date*: 2005-03-07
    Sponsor Name:Sheffield teaching Hospitals NHS Foundation Trust
    Full Title: The effects of testosterone therapy in men with pulmonary hypertension
    Medical condition: Pulmonary Hypertension
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-004281-32 Sponsor Protocol Number: SJDSSM-2 Start Date*: 2004-12-21
    Sponsor Name:San Joan de Déu. Serveis de Salut Mental
    Full Title: “Double blind, placebo-controlled study of efficacy, safety and tolerance of raloxifene as an adjuvant treatment for negative symptoms of schizophrenia in postmenopausal women” Estudio doble ciego...
    Medical condition: Trastorno esquizofrénico
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-002420-18 Sponsor Protocol Number: PTK787/ZK NET 2004 Start Date*: Information not available in EudraCT
    Sponsor Name:Prof. B. Wiedenmann, Klinik für Gastroenterologie, Charité, Campus Virchow
    Full Title: A prospective, non-randomized, non-controlled, open label, multicenter phase II Study: PTK 787/ ZK222584 in patients with advanced neuroendocrine tumors.
    Medical condition: This is a non-randomized, non-controlled, open label, multicenter phase II study to evaluate the efficacy and safety of PTK 787/ ZK 222584 in the treatment of patients with·progressive neuroendocri...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Ongoing) GB (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-000684-10 Sponsor Protocol Number: ME3301-12 Start Date*: 2004-10-28
    Sponsor Name:Meiji Seika Kaisha, Ltd.
    Full Title: A randomised, double-blind, placebo-controlled crossover study to investigate the efficacy and safety of three doses of ME3301 in patients with seasonal allergic rhinitis during allergen challenge ...
    Medical condition: seasonal allergic rhinitis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-001700-12 Sponsor Protocol Number: TTD 04-02 Start Date*: 2004-12-23
    Sponsor Name:Spanish Cooperative Group for Gastrointestinal Tomour therapy
    Full Title: Open-label, phase II, ramdomised, pilot study to evaluate the safety and efficacy of combination therapy with cetuximab and FOLFOX4 or FOLFOX4 alone in patients with EGFR-pos. colorectal cancer and...
    Medical condition: Open-label, phase II, randomised, pilot study to evaluate the safety and efficacy of combination therapy with cetuximab and FOLFOX4 or FOLFOX4 alone in patients with EGFR-positive colorectal cance...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-001737-41 Sponsor Protocol Number: Mekos 03 P335/1 Start Date*: 2004-10-01
    Sponsor Name:Mekos Laboratories AS
    Full Title: Clinical evaluation of 3 allergens for "TRUE Test Panel 3" - A phase III study
    Medical condition: With the 24 allergens currently included in the TRUE test, about 60 -70% of contact allergic reactions are detected. Thus, there is a need for expanding the number of allergens included in TRUE Tes...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-001738-17 Sponsor Protocol Number: GIMEMALAL0904 Start Date*: 2004-11-08
    Sponsor Name:G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO
    Full Title: Evaluation of the intensification of post-remissional therapy in the treatment of high-risks adult Acute Lymphoblastic Leukemia and monitoring of the minimal residual disease
    Medical condition: Patients with T- and B-ALL; Age >14 and <61 years
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10000846 Acute lymphocytic leukaemia PT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    EU Clinical Trials Register Service Desk: https://servicedesk.ema.europa.eu
    European Medicines Agency © 1995-Thu Dec 13 03:56:05 GMT 2018 | 30 Churchill Place, Canary Wharf, London E14 5EU
    Legal notice
    EMA HMA